We have found that in both human and mouse breast tumor cell lines and breast tumor CAFs, DDR2 does indeed exhibit tyrosine kinase-independent actions that can support tumor cell invasion and metastatic progression in vivo. The gene discussed is DDR2; the disease is breast neoplasm.